Cosmo updates IPO plans

Drug delivery company Cosmo (Lainate, Italy) said it plans to sell up to 3.4 million shares at CHF22-CHF28 in an IPO on the SWX Swiss Exchange and a private placement outside Switzerland and the U.S. If sold in full at CHF25, the company would raise CHF85.5 million ($69.3 million). Cosmo expects to have a market cap of CHF321.6-CHF409.3 million ($260.8-$331.9 million). Lehman and Sal. Oppenheim are joint global coordinators and joint bookrunners. The offer price and number of shares are expected on March 8, with the first day of trading planned for March 12. ...